Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN FRANCISCO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- A federal class-action lawsuit has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) following a devastating 83% drop in the biotech company’s...
-
SAN FRANCISCO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- A new class-action lawsuit is targeting KBR, Inc. (NYSE: KBR), alleging the company made misleading statements to investors in the weeks leading up...
-
SAN FRANCISCO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SAN FRANCISCO - A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth...
-
SAN FRANCISCO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- CarMax, Inc. (NYSE: KMX) shareholders endured a sharp sell-off on September 25, 2025, with the stock plummeting nearly 20% following the release of...
-
SAN FRANCISCO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- A new class action lawsuit is targeting enterprise AI software company C3.ai (NYSE: AI) and its senior leadership, alleging they misled investors...
-
SAN FRANCISCO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a...
-
SAN FRANCISCO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake...
-
SAN FRANCISCO, Oct. 18, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a...
-
SAN FRANCISCO, Oct. 18, 2025 (GLOBE NEWSWIRE) -- A new class action lawsuit is targeting enterprise AI software company C3.ai (NYSE: AI) and its senior leadership, alleging they misled investors...
-
SAN FRANCISCO, Oct. 17, 2025 (GLOBE NEWSWIRE) -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its...